FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210602006> ?p ?o ?g. }

• W4210602006 abstract "Abstract Background Quantitative three‐dimensional maps of tau neurofibrillary tangles (NFT) burden derived from dense serial histology have potential application for in‐vivo biomarker studies. We constructed a group‐level NFT burden map from 15 medial temporal lobe (MTL) specimens, majority with P rimary A ge‐ R elated T auopathy (PART) or low‐level Alzheimer’s disease neuropathologic change, and showed relatively greater NFT burden in the anterior vs. posterior MTL. We investigated whether in‐vivo MRI and PET measures in ROIs derived from this map show meaningful biological relationships. Method Multimodal in‐vivo imaging data from 292 participants in the A ging B rain C ohort were used. The group‐level NFT burden map was mapped to each participant’s MRI to define an ROI mask, further divided into anterior (aMTL) and posterior (pMTL) ROIs. Cortical thickness (N=292) and 18 F‐Flortaucipir SUVR maps (N=86) were computed. Participants’ age was correlated with average thickness in the aMTL, pMTL, and anatomically defined MTL ROIs. 18 F‐Flortaucipir uptake was compared between aMTL and pMTL. The analyses were repeated in subsets of cognitive normal participants, and those with negative amyloid PET scans. Result Cortical thickness in the aMTL ROI showed stronger correlation with age than pMTL and anatomically defined MTL subregional thickness. A polynomial fit provided the best age regression, with older participants showing a parabolic decline in thickness around age 60, when substantial NFT accumulation begins in MTL. Further, tau tracer uptake in aMTL was slightly but significantly higher than in pMTL (SUVR 1.19 vs. 1.18, p=0.02). Conclusion We demonstrate the potential use of ex‐vivo NFT burden maps for in‐vivo image analysis. NFT deposition is particularly prominent in the anterior MTL in cases without or with low amyloid burden and at early Braak stage. Prior work suggests that even in the absence of amyloid, this tangle pathology may drive neurodegeneration in the aging population. Here we show that cortical thickness, a biormarker for neurodegeneration, when measured within a histopathologically‐defined region enriched for PART NFTs in the aMTL, is better correlated with age than when measured within anatomically defined subregions, suggesting that the relationship may be driven by PART. Greater tau tracer uptake in the aMTL ROI further supports this notion." @default.
• W4210602006 created "2022-02-08" @default.
• W4210602006 creator A5000473404 @default.
• W4210602006 creator A5001809915 @default.
• W4210602006 creator A5001939326 @default.
• W4210602006 creator A5001994832 @default.
• W4210602006 creator A5005247966 @default.
• W4210602006 creator A5010506491 @default.
• W4210602006 creator A5011438418 @default.
• W4210602006 creator A5012073836 @default.
• W4210602006 creator A5012662156 @default.
• W4210602006 creator A5013083825 @default.
• W4210602006 creator A5013948282 @default.
• W4210602006 creator A5014389907 @default.
• W4210602006 creator A5019134835 @default.
• W4210602006 creator A5019161876 @default.
• W4210602006 creator A5019918561 @default.
• W4210602006 creator A5021394368 @default.
• W4210602006 creator A5023525135 @default.
• W4210602006 creator A5027871633 @default.
• W4210602006 creator A5028717029 @default.
• W4210602006 creator A5029746975 @default.
• W4210602006 creator A5030582621 @default.
• W4210602006 creator A5032613185 @default.
• W4210602006 creator A5034430279 @default.
• W4210602006 creator A5037959448 @default.
• W4210602006 creator A5041387594 @default.
• W4210602006 creator A5042424499 @default.
• W4210602006 creator A5046306832 @default.
• W4210602006 creator A5046729913 @default.
• W4210602006 creator A5046970742 @default.
• W4210602006 creator A5047108669 @default.
• W4210602006 creator A5047157013 @default.
• W4210602006 creator A5053657725 @default.
• W4210602006 creator A5055238329 @default.
• W4210602006 creator A5055259148 @default.
• W4210602006 creator A5057342287 @default.
• W4210602006 creator A5058351194 @default.
• W4210602006 creator A5059550368 @default.
• W4210602006 creator A5063984955 @default.
• W4210602006 creator A5071111160 @default.
• W4210602006 creator A5075324282 @default.
• W4210602006 creator A5081337965 @default.
• W4210602006 creator A5083670114 @default.
• W4210602006 creator A5085012715 @default.
• W4210602006 creator A5086688746 @default.
• W4210602006 date "2021-12-01" @default.
• W4210602006 modified "2023-09-27" @default.
• W4210602006 title "Application of histopathologically derived 3D tau burden map as in‐vivo region of interest for biomarker analysis" @default.
• W4210602006 doi "https://doi.org/10.1002/alz.055096" @default.
• W4210602006 hasPublicationYear "2021" @default.
• W4210602006 type Work @default.
• W4210602006 citedByCount "0" @default.
• W4210602006 crossrefType "journal-article" @default.
• W4210602006 hasAuthorship W4210602006A5000473404 @default.
• W4210602006 hasAuthorship W4210602006A5001809915 @default.
• W4210602006 hasAuthorship W4210602006A5001939326 @default.
• W4210602006 hasAuthorship W4210602006A5001994832 @default.
• W4210602006 hasAuthorship W4210602006A5005247966 @default.
• W4210602006 hasAuthorship W4210602006A5010506491 @default.
• W4210602006 hasAuthorship W4210602006A5011438418 @default.
• W4210602006 hasAuthorship W4210602006A5012073836 @default.
• W4210602006 hasAuthorship W4210602006A5012662156 @default.
• W4210602006 hasAuthorship W4210602006A5013083825 @default.
• W4210602006 hasAuthorship W4210602006A5013948282 @default.
• W4210602006 hasAuthorship W4210602006A5014389907 @default.
• W4210602006 hasAuthorship W4210602006A5019134835 @default.
• W4210602006 hasAuthorship W4210602006A5019161876 @default.
• W4210602006 hasAuthorship W4210602006A5019918561 @default.
• W4210602006 hasAuthorship W4210602006A5021394368 @default.
• W4210602006 hasAuthorship W4210602006A5023525135 @default.
• W4210602006 hasAuthorship W4210602006A5027871633 @default.
• W4210602006 hasAuthorship W4210602006A5028717029 @default.
• W4210602006 hasAuthorship W4210602006A5029746975 @default.
• W4210602006 hasAuthorship W4210602006A5030582621 @default.
• W4210602006 hasAuthorship W4210602006A5032613185 @default.
• W4210602006 hasAuthorship W4210602006A5034430279 @default.
• W4210602006 hasAuthorship W4210602006A5037959448 @default.
• W4210602006 hasAuthorship W4210602006A5041387594 @default.
• W4210602006 hasAuthorship W4210602006A5042424499 @default.
• W4210602006 hasAuthorship W4210602006A5046306832 @default.
• W4210602006 hasAuthorship W4210602006A5046729913 @default.
• W4210602006 hasAuthorship W4210602006A5046970742 @default.
• W4210602006 hasAuthorship W4210602006A5047108669 @default.
• W4210602006 hasAuthorship W4210602006A5047157013 @default.
• W4210602006 hasAuthorship W4210602006A5053657725 @default.
• W4210602006 hasAuthorship W4210602006A5055238329 @default.
• W4210602006 hasAuthorship W4210602006A5055259148 @default.
• W4210602006 hasAuthorship W4210602006A5057342287 @default.
• W4210602006 hasAuthorship W4210602006A5058351194 @default.
• W4210602006 hasAuthorship W4210602006A5059550368 @default.
• W4210602006 hasAuthorship W4210602006A5063984955 @default.
• W4210602006 hasAuthorship W4210602006A5071111160 @default.
• W4210602006 hasAuthorship W4210602006A5075324282 @default.
• W4210602006 hasAuthorship W4210602006A5081337965 @default.
• W4210602006 hasAuthorship W4210602006A5083670114 @default.
• W4210602006 hasAuthorship W4210602006A5085012715 @default.
• W4210602006 hasAuthorship W4210602006A5086688746 @default.
• W4210602006 hasConcept C126838900 @default.
• W4210602006 hasConcept C142724271 @default.

• next